Navigation Links
Par Pharmaceutical Reports Third-Quarter 2007 Results
Date:12/20/2007

(20,000) (1,150)

Net Investment Loss 4,643 3,773

Branded License Fees and Premium Paid on Equity

Investments 19,150 -

Severance Costs 1,643 7,106

Net Settlements (Gain) Losses (578) 1,502

Write-off of Accounts Receivable Relating to

Invalid Customer Deductions - 9,965

Estimated Tax on Adjustments (1,895) (8,266)

Adjusted Net Income (non-GAAP measure) $48,544 $14,626

Diluted Earnings Per Share:

Reported $1.30 $0.05

Adjusted (non-GAAP measure) $1.39 $0.42

* 2006 amounts represent $3,054 gain on sale of product rights net of

$1,904 loss on the return of inventory from a customer relating to the

same agreement.

Estimated Operating Results for Full Year 2007

ESTIMATED REPORTED GAAP RESULTS FY 2007

(in millions, except per share amounts)

Total Revenue $760 - $780

SG&A $130 - $133

R&D $75 - $80

Reported GAAP EPS (fully diluted) $1.45 - $1.50

Other supplemental information

Depreciation & amortization $24 - $26

Share-based compensation $18 - $20

IMPACT OF NON-GAAP ITEMS FY 2007

(in millions, except per share amounts)

Reported GAAP EPS (fully diluted) $1.45 - $1.50

Severance $2

Branded Milestone Payments $19

High Y
'/>"/>

SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
6. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Pharmaceutical Manufacturing Quality: Optimizing Your Internal Process for FDA Compliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... By Denise Mann HealthDay Reporter , , THURSDAY, ... of Americans take to help treat hip and knee ... increase risk for developing glaucoma, a small new study ... there is an increase of intraocular pressure (IOP) or ... of the leading causes of blindness. ...
(Date:5/23/2013)... Memorial Day Focus Spotlight on Military ... a part of the U.S. Military for more than ... it, these men and women will be honored for ... America. As veterans transition to civilian life, there ... workplace chaplaincy world. , Marketplace Chaplains, America’s original ...
(Date:5/23/2013)... “Talk. They Hear You.” a new national ... talk to children as young as nine years old ... by the Substance Abuse and Mental Health Services Administration ... SAMHSA’s 2013 National Prevention Week—an annual health observance dedicated ... and mental health issues. , SAMHSA’s latest report on ...
(Date:5/23/2013)... HOUSTON - Even while being dragged to its ... receptor fires away, sending signals that thwart the ... researchers reported in an early online publication at ... starvation often encountered by tumors, the epidermal growth ... machinery, an international team led by scientists at ...
(Date:5/23/2013)... characterized as "triple negative" carries a poor prognosis, with ... kill the cancer cells the way it,s supposed to. ... cells don,t respond to chemotherapy, and identifies a mechanism ... Dr. Shawn Li, PhD, and his team at Western,s ... protein called Numb functions to promote the death of ...
Breaking Medicine News(10 mins):Health News:Glucosamine Supplements Tied to Risk of Eye Condition 2Health News:Glucosamine Supplements Tied to Risk of Eye Condition 3Health News:Memorial Day Focus Spotlight on Military Chaplains Transitioning in the Marketplace 2Health News:Memorial Day Focus Spotlight on Military Chaplains Transitioning in the Marketplace 3Health News:New Campaign to Help Parents Talk to Younger Children About the Dangers of Underage Drinking 2Health News:When oxygen is short, EGFR prevents maturation of cancer-fighting miRNAs 2Health News:When oxygen is short, EGFR prevents maturation of cancer-fighting miRNAs 3
... for years that psychological trauma that results in ... how a person responds to stress. Now, Cornell ... ones, life-threatening accidents and other such traumas may ... doesn,t develop a clinical disorder., "The findings suggest ...
... The soaring obesity rates across the globe have been ... the 21st century. A top university researcher argues that ... this obesity epidemic. , In an article published in ... examines the vital role physicians play in managing and ...
... often assumed to be the top truants in American medicine, ... and less treatable. However, a new study by Dartmouth researchers ... slip through the cracksat least when it comes to colorectal ... two types of cancer, the study found that urban patients ...
... DALLAS, Nov. 20 Crdentia Corp. (OTC Bulletin,Board: ... the,promotion of Ms. Penny Kirsch to Vice President ... Human Resources Manager,for Crdentia and will continue to ... Kirsch will be responsible for all human resources ...
... RGEN ) announced today that the Company President and ... upcoming,healthcare conferences in New York, NY. -- Lazard Capital ... Wednesday, November 28, 2007 at 11:00 A.M. EST at the ... Avenue, New York, NY. -- BMO Capital Markets Focus ...
... CHICAGO, Nov. 20 Advanced Life Sciences,Holdings, Inc. ... will present at the,Lazard Capital Markets Fourth Annual ... audio. Advanced Life Sciences, management will,provide an overview ... http://www.newscom.com/cgi-bin/prnh/20050428/CGTH039LOGO ) The Company,s presentation will ...
Cached Medicine News:Health News:Top researcher argues most physicians aren't prepared to deal with obesity epidemic 2Health News:Rural patients' colon and lung cancers diagnosed earlier, Dartmouth research says 2Health News:Crdentia Announces Promotion of Penny Kirsch to Vice President of Human Resources 2Health News:Crdentia Announces Promotion of Penny Kirsch to Vice President of Human Resources 3Health News:Repligen to Present at Upcoming Healthcare Conferences Wednesday, November 28th and Wednesday, December 5th 2Health News:Repligen to Present at Upcoming Healthcare Conferences Wednesday, November 28th and Wednesday, December 5th 3Health News:Advanced Life Sciences to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference 2
(Date:5/23/2013)... N.Y. , May 23, 2013   ... following mastectomy is an appropriate option for ... seeking to surgically reduce their breast cancer risk, ... a gradual expansion process and a second surgery ... implants in the same surgery as mastectomy can ...
(Date:5/23/2013)... May 23, 2013 Israel Brain Technologies ... , Israel,s 1 st International ... th -15 th in Tel Aviv ... city in the world by the Wall Street Journal ... BrainTech Israel 2013 will showcase the latest breakthroughs in neuroscience ...
(Date:5/23/2013)... , May 23, 2013  Intercept Pharmaceuticals, Inc. (Nasdaq: ... company focused on the development and commercialization of novel ... as primary biliary cirrhosis, today announced that ... Officer, will present at the Deutsche Bank Securities 38th ... on Wednesday, May 29, 2013 at 4:10 p.m. ...
Breaking Medicine Technology:Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 2Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 3Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 2Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 3
... ANAHEIM, Calif., Dec. 20, 2010 Questcor Pharmaceuticals, Inc. (Nasdaq: ... at the 29th Annual J.P. Morgan Healthcare Conference at 12:00 ... St. Francis Hotel in San Francisco, California. Don M. Bailey, ... strategy and recent corporate developments. A live audio ...
... 2010 The Penn Transplant Institute, the Department of ... the Hospital of the University of Pennsylvania (HUP) have ... Program will operate under the leadership of the Penn ... Life Donor Program, the nonprofit organ and tissue donor ...
Cached Medicine Technology:Penn Medicine Establishes Hand Transplant Program 2Penn Medicine Establishes Hand Transplant Program 3Penn Medicine Establishes Hand Transplant Program 4Penn Medicine Establishes Hand Transplant Program 5
... The Advia 120 ... to streamline laboratory workflow ... benefits. This analyzer offers ... diagnostic assays, meeting the ...
The K-4500 automated hematology analyzer offers fast reliable test results of 18-parameter plus 3-histograms, valuable for effective diagnosis....
The XT-1800i is a compact, high performance, automated hematology analyzer that provides accurate and precise CBC result including a fully automated WBC 5-part differential, and comprehensive test re...
The SF-3000 automated hematology analyzer can provide accurate and precise 23-parameter hematolgy results including a fully automated WBC 5-part differential from a compact space-save design....
Medicine Products: